Dépression chez les patients tunisiens diabétiques type 2 : prévalence et association au contrôle glycémique et à la compliance thérapeutique

##plugins.themes.academic_pro.article.sidebar##

Published Dec 11, 2017
Download
pdf
Vol. 95 No. 3 (2017): Issue Mar 2017

##plugins.themes.academic_pro.article.main##

Faten Ellouze
Rahma Damak
Mehdi El Karoui
Haifa Mami
Mohamed Fadhel M'rad
Ghada Hamdi
Abdelmajid Abid

Abstract

Backgroud and Aim the comorbidity depression-diabetes was important. Ours objectives were to study the prevalence of depression in type 2 diabetes and to seek for a relationship between glycemic control and treatment adherence.
Methods This cross-sectional study was carried out at the outpatient department of the Tunis nutrition institute. A total of 100 diabetic patients followed for Type 2 diabetes were randomly recruited. We used a structured questionnaire to collect patients’ socio-demographic, clinical and therapeutic data. The treatment adherence was assessed by using MAS, Glycemic control according to blood glucose and glycated hemoglobin (HbA1c) levels and depression and anxiety by administering a dialectal Arabic validated version of Hospital Anxiety and Depression Scale (HAD). Finaly we also used the modules on mood disorders of the mini international neuropsychiatric interview (MINI)
Results: The prevalence of depression in T2DP was 38% according to the HAD scale with severe forms in 18%. The anxiety prevalence was 31%. However, 18% of T2DP had anxious-depressive co morbidity. According to the MINI, 31% of T2DP had a mood disorder. Dysthymia was noted in 14% of cases, an isolated depressive episode in 6%. Depressed T2DP have a poor glycemic control than those no depressed. Macro-angiopathy, irregular followed-up, poor treatment adherence and unbalanced diet were associated with depression
Conclusion: The detection of depression related to somatic  pathology in particular diabetes, seems essential. As a result, depression treatment may improve the overall prognosis of the associated somatic diseases.

Keywords:

Depression, Diabetes, Prevalence, Prognosis

##plugins.themes.academic_pro.article.details##

References

  1. Fédération Internationale du Diabète. IDF Diabetes Atlas. 4e éd. Bruxelles, Belgique: Fédération Internationale du Diabète 2009.
  2. Waleed S, Hanadi A, Saied Z. Prevalence of depression among people with type 2 diabetes mellitus: a cross sectional study in Palestine. BMC Public health. 2014:14:163.
  3. ElAsmi M, Feki M, Sanhaji H. Prévalence des facteurs de risque cardiovasculaires conventionnels dans la population du grand Tunis. Revue épidémiologique et de la Santé Publique 2009;57:87-92.
  4. Greden JF. Physical symptoms of depression: unmet needs. J Clin Psychiatry 2003;64:5-11.
  5. Brown LC, Majumdar SR, Newman SC, Johnson JA. History of depression increases risk of type 2 diabetes in younger adults. Diabetes Care 2005;28:1063-7.
  6. Golden SH, Lazo M, Carnethon M, Bertoni AG, Schreiner PJ, Diez Roux AV and al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA psychiatry 2008;299:2751-9.
  7. Rubin RR, Ma Y, Marrero DG, Peyrot M, Barrett-Connor EL, Kahn SE and al. Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program. Diabetes Care 2008;31:420-6.
  8. Simon GE, Katon WJ, Lin EH, Rutter C, Manning WG, Von Korff M and al. Cost-effectiveness of systematic depression treatment among people with diabetes mellitus. Arch Gen Psychiatry 2007;64:65-72.
  9. Egede LE, Nietert PJ, Zheng D. Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care 2005;28:1339-45.
  10. Katon W, Lin EH, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry 2007;29:147-55.
  11. Morisky D, Ang A, Krouselwood M, Ward H. Predictive validity of a medication adherence measure in an outpatient setting. J ClinHypertens 2008;10:348-54
  12. Malasi TH, Mirza IA, El-Islam MF.Validation of the Hospital Anxiety and Depression Scale in Arab patients. Acta PsychiatrScand 1991;84:323-6.
  13. Lépine JP, Godchau M, Brun P, Lemperiere T. Évaluation de l'anxiété et de la dépression chez des patients hospitalisés dans un service de médecine interne. Ann Med Psychol. 1985;143:175-89.
  14. Kadri N, Agoub M, El Gnaoui S, Alami KhM, Hergueta T, Moussaoui D. Moroccan colloquial Arabic version of the Mini International Neuropsychiatric Interview (MINI): qualitative and quantitative validation. Eur Psychiatry. 2005 Mar;20(2):193-5.
  15. MasmoudiJ, Damak R, Zouari GH and al. Prevalence and impact of anxiety and depression on type 2 diabetes in tunisian patients over sixty years old, Depression Research and Treatment, vol. 2013, 2013.
  16. Mendenhall E, Norris S, Shidhaye R, Prabhakran D. Depression and type 2 diabetes in low and midder income countries: a systematic review. Diabetes Res Clin Pract2014;103:276-285.
  17. Camara A, Baldéa NM, Enoruc S, Bangouraa JS, Sobngwic E, Bonnetb F. Prevalence of anxiety and depression among diabetic African patients in Guinea: Association with HbA1c levels A. Diabetes Metab. 2015 Feb;41(1):62-8.
  18. Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic review.J Affect Disord. 2012 Oct;142 Suppl:S8-21.
  19. Sumlin LL, Garcia TJ, Brown SA, and al. Depression and adherence to lifestyle changes in type 2 diabetes: a systematic review. Diabetes Educ. 2014;40:731-44.
  20. Al-Amer RM, Sobeh MM, Zayed AA, Al-Domi HA. Depression among adults with diabetes in Jordan: risk factors and relationship to blood sugar control.J Diabetes Complications. 2011;25:247-52.
  21. Talon J-M. Dépression et diabète de type 2 : à propos d'une étude prospective concernant 41 patients. Thèse en Médecine. Faculté de médecine de Besançon2005.
  22. Gavard JA, Lustman PJ, Clouse RE. Prevalence of depression in adults with diabetes:An epidemiological evaluation. Diabetes Care 1993;16:1167-78.
  23. Engum A. The role of depression and anxiety in onset of diabetes in a large population-based study. J Psychosom Res 2007;62:31-8.
  24. Thomas J, Jones G, Scarinci I, Brantley P. A descriptive and comparative study of the prevalence of depressive and anxiety disorders in low-income adults with type 2diabetes and other chronic illness. Diabetes care 2003;26:2311-7.
  25. Hermanns, N,Kulzer, B,Krichbaum,M and al. Affective and anxiety disorders in a German sample of diabetic patients: prevalence, comorbidity and risk factors. Diabet Med 2005;22:293-300.
  26. Jackson IL, Adibe MO, Okonta MJ, Ukwe CV. Medication adherence in type 2 diabetes patients in Nigeria.DiabetesTechnolTher. 2015 Jun;17(6):398-404.
  27. Lustman PJ, Clouse RE. Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complications 2005;19:113-22.
  28. Katon WJ, Young BA, Russo J, and al. Association of depression with increased risk of severe hypoglycemic episodes in patients with diabetes. Ann Fam Med. 2013;11:245-50
  29. De Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Rev Med Psychosom2001;63:619-30.
  30. Engum A, Mykluntem A. Depression and Diabetes. A large population based study of sociodemographic, lifestyle, and clinical factors associated with depression in type 1and type 2 diabetes. Diabet Care 2005;28:1904-8.
  31. Kruse J, N Schmitz, W Thelfed. On the Association Between Diabetes and Mental Disorders in a Community Sample: Results from the German National Health Interview and Examination Survey. Diabetes Care 2003;26:1841-6.